A new Horizon Europe project brings together seven partners from six countries to build the first pan-European network of knowledge valorisation intermediaries for drug discovery.
TransBioNet, a new initiative funded by the European Union’s Horizon Europe programme, has been launched to help promising biomedical research across Europe progress towards investment readiness. The nearly €2 million project brings together seven partners from six countries to establish the first pan-European network of knowledge valorisation intermediaries fully dedicated to drug discovery and biomedical innovation.
Coordinated by Associação AccelBio in Portugal, the project will address the translation gap through shared assessment tools, training, cross-border collaboration and two Open Calls supporting early-stage drug discovery projects.